What This Bill Does
This resolution recognizes endometriosis as a significant unmet chronic disease affecting American women. The Senate designates March 2023 as "Endometriosis Awareness Month" and calls on federal health agencies to increase public awareness, provide information about the disease, and conduct additional research.
Who It Affects
Women living with endometriosis, health care providers, the Secretary of Health and Human Services, the Secretary of Defense, the Secretary of Veterans Affairs.
Key Provisions
• The Senate designates March 2023 as "Endometriosis Awareness Month" (Resolved, paragraph 1).
• The Senate encourages the Secretary of Health and Human Services, the Secretary of Defense, and the Secretary of Veterans Affairs to provide information to women, patients, and health care providers about endometriosis, including available screening tools and treatment options, with a goal of improving quality of life and health outcomes (Resolved, paragraph 3(A)).
• The Senate encourages these same three secretaries to conduct additional research on endometriosis and possible clinical options (Resolved, paragraph 3(B)).
• The Senate encourages these three secretaries to update information, tools, and studies currently available to help women live with endometriosis (Resolved, paragraph 3(C)).
What Changes
Not specified in bill text. This is a resolution that recognizes the disease and encourages federal action. It does not create new laws or requirements with specified enforcement mechanisms.
Important Definitions
None defined.
III
118TH CONGRESS
1ST SESSION
S. RES. 90
Recognizing the significance of endometriosis as an unmet chronic disease
for women and designating March 2023 as ‘‘Endometriosis Awareness
Month’’.
IN THE SENATE OF THE UNITED STATES
MARCH 1, 2023
Ms. DUCKWORTH (for herself, Mrs. CAPITO, Ms. CANTWELL, Ms. KLO-
BUCHAR, Mr. BOOKER, Mr. BLUMENTHAL, and Ms. HIRONO) submitted
the following resolution; which was referred to the Committee on the Ju-
diciary
RESOLUTION
Recognizing the significance of endometriosis as an unmet
chronic disease for women and designating March 2023
as ‘‘Endometriosis Awareness Month’’.
Whereas more than 6,500,000 women in the United States
are living with endometriosis;
Whereas endometriosis is a chronic disease that can be pain-
ful and debilitating and affects—
(1) approximately 190,000,000 women throughout
the world;
(2) an estimated 1 in 10 women of reproductive age
in the United States; and
(3) primarily women in their 30s and 40s, but can
affect any woman who menstruates;
VerDate Sep 11 2014
00:00 Mar 02, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\SR90.IS
SR90
pbinns on DSKJLVW7X2PROD with $$_JOB
2
•SRES 90 IS
Whereas the cause of endometriosis is not known, but risk
factors include—
(1) having a mother, sister, or daughter with endo-
metriosis;
(2) menstrual cycles that started at an early age;
(3) menstrual cycles that are short; and
(4) periods that are heavy and last more than 7
days;
Whereas endometriosis occurs when tissue similar to that of
the lining of the uterus begins to grow outside the uterus;
Whereas, for many women, the only way currently available
to be certain of an endometriosis diagnosis is to have a
surgical procedure known as a laparoscopy;
Whereas the primary symptoms of endometriosis include pain
and infertility, and many women with endometriosis live
with debilitating, chronic pain;
Whereas symptoms of anxiety and depression are common
among women with endometriosis, with reported rates as
high as 75 to 90 percent;
Whereas, although endometriosis is one of the most common
gynecological disorders in the United States, there is a
lack of awareness and prioritization of endometriosis as
an important health issue for women;
Whereas women can suffer from endometriosis for up to 10
years before being properly diagnosed;
Whereas approximately 75 percent of women with endo-
metriosis experience a misdiagnosis;
Whereas the management of symptoms of endometriosis may
include low-dose oral contraceptives, intrauterine devices
(IUDs), painkillers, including nonsteroidal anti-inflam-
VerDate Sep 11 2014
00:00 Mar 02, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\SR90.IS
SR90
pbinns on DSKJLVW7X2PROD with $$_JOB
3
•SRES 90 IS
matory drugs (NSAIDs), and gonadotropin-releasing hor-
mone (GnRH) agonist therapy;
Whereas in vitro fertilization (IVF) is often recognized as the
best option for patients experiencing endometriosis-asso-
ciated infertility and for whom initial surgery was unsuc-
cessful;
Whereas endometriosis is associated with increased health
care costs and poses a substantial burden to patients in
the health care system;
Whereas, in the United States, the estimated average direct
health care cost associated with endometriosis per patient
is more than $13,000 per year;
Whereas 40 percent of women with endometriosis report im-
paired career growth due to endometriosis, and approxi-
mately 50 percent of women with endometriosis experi-
ence a decreased ability to work;
Whereas the Centers for Disease Control and Prevention
found that the average number of ‘‘bed days’’ for pa-
tients with endometriosis was 18 days per year;
Whereas women with endometriosis can lose 11 hours per
workweek through lost productivity;
Whereas the physical and psychological impact of endo-
metriosis affects all domains of life, including social life,
relationships, and work;
Whereas medical societies and patient groups have expressed
the need for greater public attention and updated re-
sources targeted to public education about this unmet
health need for women;
Whereas there is a need for more research and updated
guidelines to treat endometriosis;
VerDate Sep 11 2014
00:00 Mar 02, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\SR90.IS
SR90
pbinns on DSKJLVW7X2PROD with $$_JOB
4
•SRES 90 IS
Whereas there is an ongoing need for additional clinical re-
search and treatment options to manage this debilitating
disease; and
Whereas there is no known cure for endometriosis: Now,
therefore, be it
Resolved, That the Senate—
1
(1) designates March 2023 as ‘‘Endometriosis
2
Awareness Month’’;
3
(2) recognizes the importance of endometriosis
4
as a health issue for women that requires far greater
5
attention, public awareness, and education about the
6
disease;
7
(3) encourages the Secretary of Health and
8
Human Services, the Secretary of Defense, and the
9
Secretary of Veterans Affairs—
10
(A) to provide information to women, pa-
11
tients, and health care providers with respect to
12
endometriosis, including available screening
13
tools and treatment options, with a goal of im-
14
proving the quality of life and health outcomes
15
of women affected by endometriosis;
16
(B) to conduct additional research on
17
endometriosis and possible clinical options; and
18
(C) to update information, tools, and stud-
19
ies currently available with respect to helping
20
women live with endometriosis; and
21
VerDate Sep 11 2014
00:00 Mar 02, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\SR90.IS
SR90
pbinns on DSKJLVW7X2PROD with $$_JOB
5
•SRES 90 IS
(4) respectfully requests that the Secretary of
1
the Senate transmit an enrolled copy of this resolu-
2
tion to the Secretary of Health and Human Services.
3
Æ
VerDate Sep 11 2014
00:00 Mar 02, 2023
Jkt 039200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\SR90.IS
SR90
pbinns on DSKJLVW7X2PROD with $$_JOB